Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Preterm Birth Drug Withdrawn After 12 Years

The New York Times – Business:

The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Covis Pharma Group, Drugs (Pharmaceuticals), Food and Drug Administration, Pregnancy and Childbirth, Premature Babies, Recalls and Bans of Products
←Keanu Reeves Reveals He Still Owns This Epic Souvenir From The ‘Matrix’ Set
Kevin McCarthy Defends Giving Fox News’ Tucker Carlson Jan. 6 Footage→

More posts

  • New aircraft carrier heads toward Mideast after reports of issues on long-deployed USS Lincoln

  • New Zealand break with OFC to withdraw Infantino support

  • Judge dismisses Trump administration lawsuit alleging antisemitism at Harvard University

  • ‘She was just Gaynor from up the road’ – villagers ready for emotional Bonnie Tyler goodbye

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube